Core Laboratories NV (NYSE:CLB) had its price target upped by Citigroup Inc. from $110.00 to $115.00 in a research note released on Tuesday morning. The brokerage currently has a neutral rating on the stock.
Several other analysts have also weighed in on the company. Zacks Investment Research raised Core Laboratories NV from a sell rating to a hold rating in a report on Thursday, October 6th. DA Davidson began coverage on Core Laboratories NV in a report on Wednesday, October 5th. They set a buy rating and a $136.00 price objective on the stock. Loop Capital began coverage on Core Laboratories NV in a report on Friday, September 30th. They set a hold rating and a $120.00 price objective on the stock. Credit Suisse Group AG began coverage on Core Laboratories NV in a report on Thursday, September 1st. They set a neutral rating and a $115.00 price objective on the stock. Finally, JPMorgan Chase & Co. lowered Core Laboratories NV from a neutral rating to an underweight rating in a report on Tuesday, July 12th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company’s stock. Core Laboratories NV currently has an average rating of Hold and an average price target of $121.61.
Core Laboratories NV (NYSE:CLB) opened at 111.41 on Tuesday. The stock has a 50 day moving average price of $110.58 and a 200 day moving average price of $117.47. Core Laboratories NV has a 1-year low of $84.50 and a 1-year high of $135.49. The company has a market cap of $4.91 billion, a PE ratio of 59.10 and a beta of 1.45.
Core Laboratories NV (NYSE:CLB) last announced its quarterly earnings data on Wednesday, July 20th. The company reported $0.35 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.35. Core Laboratories NV had a return on equity of 344.55% and a net margin of 11.81%. The company had revenue of $148.10 million for the quarter, compared to analyst estimates of $146.37 million. During the same quarter last year, the firm earned $0.81 EPS. Core Laboratories NV’s revenue for the quarter was down 27.4% compared to the same quarter last year. Equities analysts forecast that Core Laboratories NV will post $1.54 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 22nd. Investors of record on Friday, October 21st will be paid a dividend of $0.55 per share. The ex-dividend date is Wednesday, October 19th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 1.97%. Core Laboratories NV’s dividend payout ratio (DPR) is presently 117.65%.
Several large investors have recently made changes to their positions in CLB. Emerald Acquisition Ltd. bought a new stake in shares of Core Laboratories NV during the second quarter worth approximately $110,515,000. Royal Bank of Canada boosted its stake in shares of Core Laboratories NV by 416.8% in the second quarter. Royal Bank of Canada now owns 475,077 shares of the company’s stock worth $58,857,000 after buying an additional 383,153 shares during the period. Fiera Capital Corp bought a new stake in shares of Core Laboratories NV during the second quarter worth approximately $26,853,000. WCM Investment Management CA boosted its stake in shares of Core Laboratories NV by 5.3% in the second quarter. WCM Investment Management CA now owns 3,588,166 shares of the company’s stock worth $444,538,000 after buying an additional 181,958 shares during the period. Finally, Sustainable Growth Advisers LP boosted its stake in shares of Core Laboratories NV by 17.2% in the second quarter. Sustainable Growth Advisers LP now owns 1,136,488 shares of the company’s stock worth $140,799,000 after buying an additional 166,978 shares during the period.
About Core Laboratories NV
Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.
Receive News & Ratings for Core Laboratories NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories NV and related companies with MarketBeat.com's FREE daily email newsletter.